CSX — CSX Corporation

The prevailing market read on CSX as of 2026-09-13 is bullish, even though the tape has softened. The Q2 2026 print (released 2026-07-22) beat on both lines - revenue $3.935B vs ~$3.6B a year ago, EPS $0.54 vs $0.44, operating margin 38.3% vs 35.9% - and management raised FY guidance to mid-to-high single-digit revenue growth, >350bps operating margin expansion, and >80% FCF growth. Analysts followed: Barclays went $55 to $60, BofA $53 to $56, RBC $51 to $54, with a 16-analyst consensus target of ~$51-52 and a Buy rating (27 buy / 17 hold / 2 sell). The stock ran to $53.60 and then gave back ~9% into mid-September, so the last month (-2.26%) looks like profit-taking after the news rather than a change in story. The 6-month return of +24.55% tells you which direction the crowd has been leaning.

The three-year quarterly record shows a clear two-year fade followed by an inflection in 2026. Revenue was essentially flat through 2023-2024 ($3.68B Q1 2024 to $3.539B Q4 2024), bottomed at $3.423B in Q1 2025, and has now accelerated for three straight quarters: $3.587B (Q3 2025), $3.508B (Q4 2025), $3.482B (Q1 2026), $3.935B (Q2 2026, a record and +10.1% YoY). The margin story is the same shape. Operating margin peaked at 38.7% in Q2 2024 ($1.432B op income), slid to 30.4% in Q1 2025 and 30.3% in Q3 2025, then rebuilt to 36.0% in Q1 2026 ($1.253B, +20% YoY) and 38.3% in Q2 2026 ($1.506B, +17.4% YoY). EPS followed: $0.45 (Q2 2024) to $0.34 (Q1 2025 trough) to $0.43 then $0.54. Free cash flow is the most dramatic tell - FY2025 collapsed to roughly $946M as quarterly capex spiked (Q3 2025 capex alone was $1.495B, producing -$158M FCF), while H1 2026 has already produced $1.48B ($729M + $751M) versus just $395M in H1 2025. This is not a one-quarter blip: two consecutive quarters of YoY margin expansion, a record revenue quarter, and a guidance raise indicate a genuine cyclical turn, not noise.

Expensive relative to its own history, and only defensible if the margin recovery sticks. As of 2026-09-13 the stock carried a TTM P/E of 28.3x against a 5-year average of 19.76x, a P/S of 6.25x against a 5-year average of 5.01x, a PEG of 4.61, and P/B of 6.45x. Forward math is kinder but still full: at $48.95 against the ~$2.008 FY2026 consensus EPS, the forward P/E is about 24.4x - roughly 23% above the trailing 5-year average. EV/EBITDA of 16.3x is also a premium to the 12-14x that Class I railroads have historically commanded. The counter-argument is that the trailing numbers are depressed: TTM EPS of $1.737 will grow to ~$2.01 in FY2026 (+30%), so on FY2027 numbers (~$2.20 by my estimate) the multiple compresses toward 22x. Even so, paying a premium multiple for high-single-digit EPS growth leaves no room for error.

The stock is pricing in an inflection that has only two quarters of evidence behind it. At $48.95 the market is paying ~24.4x FY2026E EPS of $2.008 and ~22x my FY2027E of ~$2.20. That means H2 2026 and the Q3 print must validate management's raised bar: mid-to-high single-digit revenue growth, >350bps of margin expansion, and >80% FCF growth. If H2 volumes stall and FY2026 EPS lands near $2.01 with FY2027 near $2.15, a de-rating to the 5-year average of ~20x trailing - call it 21x forward - implies roughly $44-45, about 8-10% downside. If margin expansion overshoots and EPS runs to $2.25 in FY2027, a 24x multiple gets you to ~$54 and the current consensus target near $51-52 looks conservative. The asymmetry is roughly balanced to slightly negative at today's price; the payoff improves meaningfully below $45.

As of 2026-09-13, CSX showed a cooling uptrend rather than a broken one. RSI(14) sat at 42.11 - mildly weak, not oversold. Price was 2.43% below the 20-day SMA (~$50.17) and 2.52% below the 50-day SMA (~$50.22), but 12.64% above the 200-day SMA (~$43.46), and the 6-month return was +24.55% against a 1-month return of -2.26%. Translation: the intermediate trend is still up, but short-term momentum has flipped negative after the post-earnings run to $53.60. This is not a washed-out entry point - RSI would need to be in the 30s with price near the 200-day to call it that. Practically, a reclaim of the 50-day near $50.20 would confirm the uptrend resuming; a drift toward the $45-47 zone (or a deeper flush toward the 200-day in the low $40s) would be the better risk/reward entry.

• Trucking capacity cycle: a relatively tight truckload market has been pushing highway-to-rail intermodal conversions, which drove the 9% intermodal volume surge in Q2 2026 - if truck spot rates collapse, that tailwind reverses and intermodal pricing power weakens.
• Industrial and construction demand: manufacturing activity, data-center build-outs, and infrastructure projects feed the merchandise segment (chemicals, aggregates, steel, automotive), which is the margin-rich core of the franchise.
• Interest rates and the cost of capital: CSX carries $17.162B of long-term debt against $14.082B of equity (D/E 1.375), and rail capex is enormous, so rates affect both interest expense and the relative attractiveness of railroad equities versus bonds.
• Coal's secular decline: utility and export coal volumes keep eroding as natural gas and renewables displace coal-fired generation, permanently shrinking a historically significant revenue line.
• Trade policy and regulation: tariffs and cross-border flows with Canada and Mexico affect volumes, while Surface Transportation Board oversight of rates and potential reciprocal-switching rules remain an evergreen regulatory overhang for all Class I rails.

• Q3 2026 earnings (historically mid-to-late October 2026) - the first hard test of the raised guidance for H2 volume growth and >350bps of full-year operating margin expansion.
• Weekly and monthly AAR carload/intermodal traffic reports, which give a real-time read on whether the 6% total volume growth and 9% intermodal growth from Q2 are holding.
• Continued intermodal conversion wins if truckload capacity stays tight, plus any incremental industrial reshoring or data-center construction freight announcements.
• Capital return: buybacks have reduced the share count (market cap of $90.7B at $48.95 implies ~1.85B shares), and the 1.089% dividend yield is covered roughly 2x by FY2026E free cash flow - a raise or an accelerated repurchase would be a positive.

• Valuation risk is the single biggest: 28.3x trailing and ~24.4x forward versus a 5-year average P/E of 19.76x means any disappointment in the H2 volume or margin story can trigger an outsized de-rating.
• Volume cyclicality cuts both ways - the 2024-2025 experience shows how fast margins compress. Operating margin fell to 30.3% in Q3 2025 from 37.5% in Q3 2024; a repeat of that freight recession would gut the recovery narrative.
• Balance sheet leverage: $17.162B of long-term debt, D/E of 1.375, current ratio of 0.82 and quick ratio of 0.72 - low current ratios are normal for railroads, but the debt load is real and interest-rate sensitive.
• Coal's structural decline and any deterioration in export coal demand from weaker global industrial activity.
• Cost inflation in labor, fuel, and equipment maintenance, plus the risk that trucking capacity normalizes and erodes the intermodal pricing advantage that has been driving the current beat.

CSX is a genuinely high-quality, wide-moat eastern railroad in a real operating recovery - record Q2 2026 revenue of $3.935B, operating margin back to 38.3% from 30.3% a year and a half ago, free cash flow swinging from -$141M to +$751M year over year, and guidance raised. The problem is price, not business quality: at $48.95 on 2026-09-13 you are paying ~24.4x forward earnings against a 5-year average trailing P/E of 19.76x, so most of the recovery is already in the stock. This is a good business at a full price - own it on a pullback toward the mid-$40s or wait for another quarter or two of proof, not at today's level.

Two independent methods averaged. (1) P/E: a 22x forward multiple (a premium to the 19.76x five-year trailing average, justified by the margin inflection but below the current 24.4x forward) applied to a blended forward EPS of ~$2.10 - the $2.008 FY2026 consensus plus my FY2027 estimate of ~$2.20, built from ~5% revenue growth to roughly $16B at a ~37% operating margin, ~$0.78B interest expense and ~1.82B shares - gives $46.20. (2) EV/EBITDA: 14.5x FY2026E EBITDA of ~$7.2B (FY2026E revenue of ~$15.2B at a ~36.5% operating margin plus ~$1.65B of D&A), less ~$16.2B of net debt on 1.85B shares, gives $47.60. Average = $47, which sits about 4% below the 2026-09-13 price of $48.95 and well under the ~$51-52 analyst consensus.